Pharmacoproteomic investigation into antidepressant response in two mouse inbred strainsMALKI, Karim; CAMPBELL, James; KUHN, Karsten et al.Proteomics (Weinheim. Print). 2012, Vol 12, Num 14, pp 2355-2365, issn 1615-9853, 11 p.Article

PharmGKB summary: citalopram pharmacokinetics pathwaySANGKUHL, Katrin; KLEIN, Teri E; ALTMAN, Russ B et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 11, pp 769-772, issn 1744-6872, 4 p.Article

Column Liquid Chromatography-Ultraviolet and Column Liquid Chromatography/Mass Spectrometry Evaluation of Stress Degradation Behavior of Escitalopram OxalateDHANESHWAR, Sunil R; MAHADIK, Mahadeo V; KULKARNI, Mahesh J et al.Journal of AOAC International. 2009, Vol 92, Num 1, pp 178-187, issn 1060-3271, 10 p.Article

Spectrophotometric and Reversed-Phase High-Performance Liquid Chromatographic Methods for Simultaneous Determination of Escitalopram Oxalate and Clonazepam in Combined Tablet Dosage FormSANTOSH VILASHCHAND GANDHI; NILESH DNYANDEV DHAVALE; VIJAY YESHAWANTRAO JADHAV et al.Journal of AOAC International. 2008, Vol 91, Num 1, pp 33-38, issn 1060-3271, 6 p.Article

An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: Kinetic binding studies with the ALI/VFL-SI/TT mutantHUAILING ZHONG; HANSEN, Kasper B; BOYLE, Noel J et al.Neuroscience letters. 2009, Vol 462, Num 3, pp 207-212, issn 0304-3940, 6 p.Article

Differential effects of escitalopram challenge on disgust processing in obsessive―compulsive disorderLOCHNER, Christine; SIMMONS, Candice; KIDD, Martin et al.Behavioural brain research. 2012, Vol 226, Num 1, pp 274-280, issn 0166-4328, 7 p.Article

De nouvelles données pour appréhender les mécanismes d'action des antidépresseurs : l'apport du Escitalopram = Mechanisms of action of antidepressants : new data from EscitalopramFABRE, V; HAMON, M.L' Encéphale (Paris). 2003, Vol 29, Num 3, pp 259-265, issn 0013-7006, 7 p., CAH1Article

Therapeutic Drug Monitoring of Escitalopram in an Outpatient SettingREIS, Margareta; CHERMD, Maria D; CARLSSON, Björn et al.Therapeutic drug monitoring. 2007, Vol 29, Num 6, pp 758-766, issn 0163-4356, 9 p.Article

R-citalopram prevents the neuronal adaptive changes induced by escitalopramMNIE-FILALI, Ouissame; FAURE, Céline; EL MANSARI, Mostafa et al.Neuroreport (Oxford). 2007, Vol 18, Num 15, pp 1553-1556, issn 0959-4965, 4 p.Article

The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopramO'BRIEN, Fionn E; O'CONNOR, Richard M; CLARKE, Gerard et al.Behavioural brain research. 2014, Vol 261, pp 17-25, issn 0166-4328, 9 p.Article

Escitalopram Related Erectile Dysfunction and Spontaneous Ejaculation during MicturitionBELLI, H; ASLANER, D; URAL, C et al.West indian medical journal. 2010, Vol 59, Num 6, pp 715-716, issn 0043-3144, 2 p.Article

Bioequivalence of Two Formulations of EscitalopramALMEIDA, S; PEDROSO, P; FILIPE, A et al.Arzneimittel-Forschung. 2012, Vol 62, Num 7, pp 307-312, issn 0004-4172, 6 p.Article

Escitalopram—translating molecular properties into clinical benefit: reviewing the evidence in major depressionLEONARD, Brian; TAYLOR, David.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 8, pp 1143-1152, issn 0269-8811, 10 p.Article

Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?MONTGOMERY, Stuart A; MÖLLER, Hans-Jürgen.International clinical psychopharmacology. 2009, Vol 24, Num 3, pp 111-118, issn 0268-1315, 8 p.Article

Increasing escitalopram dose is associated with fewer discontinuations than switch or combination approaches in patients initially on escitalopram 10 mgSANGLIER, T; MILEA, D; SARAGOUSSI, D et al.European psychiatry. 2012, Vol 27, Num 4, pp 250-257, issn 0924-9338, 8 p.Article

Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression modelPETERSEN, Asa; WÖRTWEIN, Gitta; GRUBER, Susanne H. M et al.Neuroscience letters. 2008, Vol 436, Num 3, pp 305-308, issn 0304-3940, 4 p.Article

Traitement des épisodes dépressifs sévères: escitalopram est plus efficace que citalopram = Escitalopram is more effective than citalopram for the treatment of severe major depressive disorderAZORIN, J.-M; LLORCA, P.-M; DESPIEGEL, N et al.L' Encéphale (Paris). 2004, Vol 30, Num 2, pp 158-166, issn 0013-7006, 9 p.Article

ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatmentLIN, Keh-Ming; CHIU, Yen-Feng; LIU, Shen-Ing et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 4, pp 163-170, issn 1744-6872, 8 p.Article

Transfer of escitalopram and its metabolite demethylescitalopram into breastmilkRAMPONO, Jonathan; HACKETT, L. Peter; KRISTENSEN, Judith H et al.British journal of clinical pharmacology. 2006, Vol 62, Num 3, pp 316-322, issn 0306-5251, 7 p.Article

Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorderLEPOLA, Ulla; WADE, Alan; ANDERSEN, Henning Friis et al.International clinical psychopharmacology. 2004, Vol 19, Num 3, pp 149-155, issn 0268-1315, 7 p.Article

Improvements in white matter micro-structural integrity of right uncinate fasciculus and left fronto-occipital fasciculus of remitted first-episode medication-naïve panic disorder patientsLAI, Chien-Han; WU, Yu-Te; YU, Pei-Ling et al.Journal of affective disorders. 2013, Vol 150, Num 2, pp 330-336, issn 0165-0327, 7 p.Article

Efficacité clinique et obtention d'une rémission complète dans la dépression: intérêt de l'escitalopram = Clinical efficacy and achievement of a complete remission in depression: Increasing interest in treatment with escitalopramFAVRE, P.L' Encéphale (Paris). 2012, Vol 38, Num 1, pp 86-96, issn 0013-7006, 11 p.Article

History of suicide attempts among patients with depression in the GENDEP projectPERROUD, Nader; UHER, Rudolf; DMITRZAK-WEGLARZ, Monika et al.Journal of affective disorders. 2010, Vol 123, Num 1-3, pp 131-137, issn 0165-0327, 7 p.Article

The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotypeKELLNER, Michael; MUHTZ, Christoph; DEMIRALAY, Cüneyt et al.Journal of psychiatric research. 2009, Vol 43, Num 6, pp 642-648, issn 0022-3956, 7 p.Article

Effects of escitalopram on ethanol withdrawal syndrome in ratsSAGLAM, Esra; KAYIR, Hakan; CELIK, Turgay et al.Progress in neuro-psychopharmacology & biological psychiatry. 2006, Vol 30, Num 6, pp 1027-1032, issn 0278-5846, 6 p.Article